Abstract
The mechanism(s) by which Mycobacterium tuberculosis crosses the alveolar wall to establish infection in the lung is not well known. In an attempt to better understand the mechanism of translocation and create a model to study the different stages of bacterial crossing through the alveolar wall, we established a two-layer transwell system. M. tuberculosis H37Rv was evaluated regarding the ability to cross and disrupt the membrane. M. tuberculosis invaded A549 type II alveolar cells with an efficiency of 2 to 3% of the initial inoculum, although it was not efficient in invading endothelial cells. However, bacteria that invaded A549 cells were subsequently able to be taken up by endothelial cells with an efficiency of 5 to 6% of the inoculum. When incubated with a bicellular transwell monolayer (epithelial and endothelial cells), M. tuberculosis translocated into the lower chamber with efficiency (3 to 4%). M. tuberculosis was also able to efficiently translocate across the bicellular layer when inside monocytes. Infected monocytes crossed the barrier with greater efficiency when A549 alveolar cells were infected with M. tuberculosis than when A549 cells were not infected. We identified two potential mechanisms by which M. tuberculosis gains access to deeper tissues, by translocating across epithelial cells and by traveling into the blood vessels within monocytes.
MeSH Terms
Biological Transport
Cell Line
Cell Polarity
Cells, Cultured
Chemokine CCL2/biosynthesis
Chemotaxis, Leukocyte/physiology
Endothelium, Vascular/cytology,immunology,physiology
Epithelial Cells/cytology,immunology,physiology
Humans
Interleukin-8/biosynthesis
Lung/cytology,immunology,microbiology,physiology
Models, Biological
Monocytes/cytology,immunology,microbiology,physiology
Mycobacterium bovis/physiology
Mycobacterium tuberculosis/immunology,physiology
Phagocytes/cytology,physiology
Pulmonary Alveoli/immunology,microbiology,physiology
Receptors, Cell Surface/metabolism,physiology
Chemicals
Chemokine CCL2
Interleukin-8
Receptors, Cell Surface
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bermudez Luiz E
Kuzell Institute for Arthritis & Infectious Diseases, California Pacific Medical Center Research Institute, University of California, San Francisco, California, USA.
[email protected]
Sangari Felix J
Kolonoski Peter
Petrofsky Mary
Goodman Joseph
References (20)
20 references, click to expand
-
Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway.
Infect Immun. 1997 May;65(5):1916-25
PMID: 9125580
-
Cytokine production at the site of disease in human tuberculosis.
Infect Immun. 1993 Aug;61(8):3482-9
PMID: 8335379
-
Mycobacterium tuberculosis invades and replicates within type II alveolar cells.
Infect Immun. 1996 Apr;64(4):1400-6
PMID: 8606107
-
Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.
J Immunol. 1993 Mar 1;150(5):1838-45
PMID: 8436819
-
An in vitro tissue culture bilayer model to examine early events in Mycobacterium tuberculosis infection.
Infect Immun. 1999 Feb;67(2):653-8
PMID: 9916072
-
The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis.
Immunity. 1999 Jun;10(6):641-50
PMID: 10403639
-
Mycobacterium tuberculosis infection in complement receptor 3-deficient mice.
J Immunol. 2000 Sep 1;165(5):2596-602
PMID: 10946287
-
Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.
J Exp Med. 1956 Nov 1;104(5):737-62
PMID: 13367341
-
Mycobacterium avium enters intestinal epithelial cells through the apical membrane, but not by the basolateral surface, activates small GTPase Rho and, once within epithelial cells, expresses an invasive phenotype.
Cell Microbiol. 2000 Dec;2(6):561-8
PMID: 11207608
-
Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice.
Infect Immun. 2000 Feb;68(2):577-83
PMID: 10639420
-
PHAGOCYTOSIS OF TUBERCLE BACILLI BY RABBIT PULMONARY ALVEOLAR MACROPHAGES AND ITS RELATION TO NATIVE RESISTANCE TO TUBERCULOSIS.
J Immunol. 1963 Oct;91:553-6
PMID: 14082043
-
Tuberculin skin test survey in a pediatric population with high BCG vaccination coverage -- Botswana, 1996.
MMWR Morb Mortal Wkly Rep. 1997 Sep 12;46(36):846-51
PMID: 9302224
-
Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis.
Infect Immun. 1995 Dec;63(12):4802-11
PMID: 7591139
-
Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication.
Infect Immun. 1996 Jul;64(7):2673-9
PMID: 8698494
-
Monocyte migration through the alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines.
J Immunol. 2000 Jan 1;164(1):427-35
PMID: 10605039
-
Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods.
Antimicrob Agents Chemother. 1987 Nov;31(11):1697-702
PMID: 3124736
-
Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice.
Infect Immun. 1999 Sep;67(9):4912-6
PMID: 10456949
-
Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis.
Infect Immun. 1998 Mar;66(3):1121-6
PMID: 9488404
-
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.
Nature. 2001 Jul 12;412(6843):190-4
PMID: 11449276
-
Permanent cell line expressing human factor VIII-related antigen established by hybridization.
Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734-7
PMID: 6407019